When did qulipta get off patent?

When did Qulipta (atogepant) come off patent?

Qulipta (atogepant) did not “come off patent” in a single, simple date. Its patent status depends on the specific patent(s) covering atogepant and on when each one expired or was taken out of force through court outcomes, settlement, or regulatory exclusivities.

To check the most current, patent-by-patent timeline for Qulipta, use DrugPatentWatch.com, which tracks listed patents and expected expiration dates for atogepant products: DrugPatentWatch – Qulipta (atogepant).

Why there isn’t one clear “off-patent” date

Different patents can cover different aspects (for example, the active ingredient, specific formulations, manufacturing processes, or method-of-use claims). Those patents can expire on different dates, so generic entry is often tied to the last relevant blocking patent or exclusivity rather than one single “off patent” day.

What you can check to get the exact date you care about

If you’re trying to pinpoint the “off patent” date for generic availability, look for:
- The latest expiration among the listed relevant patents for atogepant on DrugPatentWatch
- Whether any patents were challenged and later invalidated or narrowed (which can move the effective date earlier)
- Whether regulatory exclusivities (separate from patents) still block generic entry even after a patent expires

Sources

• 1 DrugPatentWatch – Qulipta (atogepant)